In the French pharmaceutical industry, there were 6 M&A deals announced in Q4 2023, worth a total value of $7.4bn, according to GlobalData’s Deals Database. The $6.9bn acquisition of Viatris by Cooper Consumer Health and IQuest Enterprises was the industry’s largest disclosed deal. GlobalData’s Pharmaceuticals Industry Mergers and Acquisitions Deals by Top Themes report for 2023 dissects the driving forces behind the M&A dynamics within the Pharma sector, offering essential insights into industry trends and transformations. Buy the report here.
In value terms, M&A activity in France increased by 46150% in Q4 2023 compared with the previous quarter’s total of $16m and rose by 4625% as compared to Q4 2022. Related deal volume increased by 20% in Q4 2023 versus the previous quarter.
The top-ranked financial advisors supporting these M&A deals in France in Q4 2023 were BNP Paribas; Clearwater International; Jefferies Financial Group with 2, 2, 2 deals respectively.
The top-ranked legal advisorss supporting these M&A deals in France Q4 2023 were CMS Legal Services EEIG; Kirkland & Ellis; White & Case with 2, 2, 2 deals respectively.
For further understanding of GlobalData's Pharmaceuticals Industry M&A Deals by Top Themes in 2023 – Thematic Intelligence, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.